CClinicalTrials.gg
Status unknownNCT03152812Updated May 23, 2017

Functional Outcome of Free Muscle Flaps Versus Free Skin Flaps for Post-traumatic Foot Plantar Surface Reconstruction

An observational study in Best Tissue Constituent for Plantar Surface, sponsored by alhussein Ahmed Mahmoud El-Dahshan. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2017-05-23.

Sponsored by alhussein Ahmed Mahmoud El-Dahshan · Observational

The sponsor has not verified this record recently (last verified May 2017), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Sex
All
01

Study summary

the investigators are trying to detect what is the best tissue constituent suitable for reconstruction of large post traumatic sof tissue defects of foot plantar surface

02

Conditions studied

  • Best Tissue Constituent for Plantar Surface
03

In context

Lead sponsor

This is the only study on the registry with alhussein Ahmed Mahmoud El-Dahshan as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

any individual having post traumatic soft tissue defect of plantar surface requiring free flap reconstruction regardless to age

Inclusion criteria

  1. Posttraumatic large soft tissue defects of plantar surface requiring free tissue transfer for coverage
  2. At any age

Exclusion criteria

Exclusion Criteria:

1-defects that can be managed by local flaps 2-Non traumatic soft tissue defects

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • free skin flaps

    Procedure: plantar surface reconstruction by free flaps

  • free muscle flaps

    Procedure: plantar surface reconstruction by free flaps

Interventions

  • Procedureplantar surface reconstruction by free flaps

    use of free skin or free muscle flaps for reconstruction of plantar surface

06

What researchers measure

Primary outcomes

  1. Time to mobilize

    Time frame: 2 years

  2. Requirement of specialized Footwear

    Time frame: 2 years

Secondary outcomes

  1. flap ulceration

    Time frame: 2 years

  2. Shear forces across the flap

    Time frame: 2 years

07

Study locations

1 site
  • Assiut University
    Assuit, Assiut 7771, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03152812
Lead sponsor
alhussein Ahmed Mahmoud El-Dahshan
Responsible party
alhussein Ahmed Mahmoud El-Dahshan (Principal investigator, Assiut University) — Sponsor-investigator
First posted
May 15, 2017
Start date
Mar 1, 2017
Primary completion
Mar 2019 (estimated)
Completion
Mar 2019 (estimated)
Last update
May 23, 2017

Study contacts

Amr El-Said Ali Ibrahim, MD
study director · Assiut University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion